Tendinopathy Diagnostic Algorithm: A Step-by-Step Clinical Approach

Step 1: Structured Clinical History

A thorough history is the diagnostic foundation. The 2021 International Scientific Tendinopathy Symposium (ICON) consensus defined tendinopathy as persistent tendon pain, loss of function related to mechanical loading, and localized tenderness, confirming that history alone narrows the diagnosis in most presentations [1].

Clinicians should ask five targeted questions. First: where exactly is the pain? Mid-substance Achilles pain differs from insertional Achilles pain, and each maps to distinct pathology and management. Second: does the pain follow a load-dependent pattern? Tendinopathy characteristically worsens with energy-storage activities (running, jumping, gripping) and eases with complete rest, only to return when load resumes [2]. Third: how long have symptoms persisted? The 3-month threshold separates acute tendon injuries from the chronic degenerative process properly termed tendinopathy. Fourth: is there morning stiffness that resolves within 30 to 60 minutes of movement? This "warm-up" phenomenon is a hallmark feature. Fifth: what is the training or occupational load history? A spike in volume, intensity, or repetitive manual work frequently precedes symptom onset.

A 2019 systematic review in the British Journal of Sports Medicine (Malliaras et al.) found that a sudden increase in training load of more than 30% over two weeks was the single strongest modifiable risk factor for lower-limb tendinopathy [3]. Document comorbidities. Metabolic conditions (type 2 diabetes, dyslipidemia, obesity) alter tendon composition and healing capacity. Fluoroquinolone use within the preceding 6 months raises the risk of tendon disorders roughly two-fold, according to an FDA black-box warning reaffirmed in 2018 [4].

Step 2: Physical Examination and Load-Provocation Testing

The exam confirms what the history suggests. Three elements matter most: palpation tenderness at the tendon's known pain site, reproduction of pain under load, and absence of findings that point elsewhere.

Palpation should be precise. For the Achilles, the examiner palpates the mid-portion (2 to 6 cm above the calcaneal insertion) and the insertion separately. Patellar tendinopathy typically localizes to the inferior pole of the patella. Lateral epicondyle pain centers on the common extensor origin. Rotator cuff tendinopathy concentrates over the greater tuberosity and supraspinatus insertion [5].

Load-provocation tests are site-specific. For Achilles tendinopathy, single-leg heel raises on a step edge provoke recognizable pain. For patellar tendinopathy, the single-leg decline squat at 25 degrees on a decline board is the reference standard. Tennis elbow responds to resisted wrist extension with the elbow straight (Cozen's test) and resisted middle-finger extension (Maudsley's test). Rotator cuff tendinopathy is provoked by the empty-can test, Jobe's test, or resisted external rotation depending on which tendon is involved [6].

Range of motion is often preserved. That distinction separates tendinopathy from adhesive capsulitis (frozen shoulder) or advanced arthritic change. Strength testing may reveal pain-inhibited weakness, but true structural weakness suggests a partial or full-thickness tear rather than isolated tendinopathy.

Bilateral comparison is non-negotiable. Comparing the symptomatic side to the contralateral tendon on palpation, thickness, and pain-provocation response improves specificity and helps the clinician avoid over-diagnosing normal anatomical variation.

Step 3: Validated Outcome Scoring

Quantifying severity at baseline allows clinicians to track treatment response and make objective decisions about progression. Two instruments dominate the literature.

The VISA-A (Victorian Institute of Sport Assessment, Achilles) is an 8-item questionnaire scored 0 to 100, where 100 represents a fully functional, pain-free tendon. A score below 50 typically indicates moderate-to-severe dysfunction. Robinson et al. (2001) established reliability with an intraclass correlation coefficient of 0.93, and the tool has been validated in over 15 languages [7]. The VISA-P serves the same role for patellar tendinopathy, with similar psychometric properties [8].

For lateral elbow tendinopathy, the Patient-Rated Tennis Elbow Evaluation (PRTEE) is the best-validated tool. The DASH (Disabilities of the Arm, Shoulder, and Hand) questionnaire is widely used for rotator cuff tendinopathy but is not tendon-specific. Scoring at initial evaluation, at 6 weeks, and at 12 weeks provides the minimum data needed to determine whether a conservative loading program is producing measurable change.

Step 4: Imaging (When, What, and Why)

Imaging is not required for every tendinopathy diagnosis. A 2018 consensus statement from the European Society of Musculoskeletal Radiology (ESSR) recommended imaging only when the clinical presentation is atypical, symptoms fail to respond to 6 to 12 weeks of structured loading, or surgical planning is needed [9].

Musculoskeletal ultrasound is the first-line imaging modality. It is accessible, dynamic, allows real-time comparison with the contralateral side, and avoids radiation. Ultrasound findings consistent with tendinopathy include fusiform tendon thickening, hypoechoic regions within the tendon substance, loss of the normal fibrillar pattern, and neovascularization on power Doppler [10]. A meta-analysis by Defined and colleagues (2019) reported pooled sensitivity of 88% and specificity of 90% for detecting structural Achilles tendon changes on ultrasound compared with histopathologic or MRI reference standards [3].

MRI offers superior soft-tissue contrast and is preferred when the clinician suspects an intra-articular pathology, a partial-thickness tear that may require surgery, or when ultrasound findings are equivocal. On T2-weighted sequences, tendinopathy appears as increased signal intensity within the tendon substance without a discrete fluid-filled gap (which would suggest a tear) [11]. MRI is the reference standard for rotator cuff assessment before considering surgical intervention, as recommended by the American Academy of Orthopaedic Surgeons (AAOS) 2019 clinical practice guideline [12].

A critical principle: imaging findings must correlate with symptoms. Asymptomatic tendon abnormalities are common. A 2015 study in the British Journal of Sports Medicine showed that 59% of asymptomatic runners had ultrasonographic Achilles tendon changes [13]. Treating an image, not a patient, leads to unnecessary procedures.

Step 5: Differential Diagnosis and Red Flags

The algorithm's final step is ruling out conditions that mimic tendinopathy. Misdiagnosis delays appropriate care.

Partial or full-thickness tendon tears present with acute onset (often a "pop"), significant weakness, and may show a palpable gap. Night pain unresponsive to position changes raises concern for malignancy or infection, not tendinopathy. Rapid bilateral tendon pain in a patient taking fluoroquinolones should prompt immediate drug discontinuation and rheumatology referral [4].

Site-specific mimics require attention. Achilles tendinopathy may be confused with retrocalcaneal bursitis, Haglund's deformity, or posterior ankle impingement. The "Royal London Hospital test" (pain on palpation that decreases with ankle dorsiflexion) helps differentiate mid-portion tendinopathy from paratenon pathology [14]. Patellar tendinopathy overlaps with patellofemoral pain syndrome, but patellofemoral pain typically worsens with prolonged sitting and stair descent rather than jumping and sprinting. Lateral epicondyle tendinopathy must be distinguished from radial tunnel syndrome, which causes pain more distally (3 to 5 cm from the epicondyle) and worsens with resisted supination. Rotator cuff tendinopathy overlaps with subacromial bursitis and acromioclavicular joint pathology. A diagnostic subacromial lidocaine injection that eliminates pain supports a subacromial source [15].

Systemic conditions to screen for include diabetes mellitus (HbA1c >6.5% is associated with impaired tendon healing), hypothyroidism, familial hypercholesterolemia, and rheumatologic disease. The Endocrine Society's 2023 guideline on musculoskeletal manifestations of metabolic disease noted that individuals with type 2 diabetes have a 3.3-fold increased risk of tendinopathy compared with age-matched controls [16].

Putting the Algorithm Together: Clinical Decision Flow

The complete algorithm follows a sequential, branching logic. Start with history. If the patient reports load-dependent tendon pain lasting more than 3 months with a recognizable mechanical pattern, proceed to examination.

On exam, confirm localized palpation tenderness and a positive site-specific load-provocation test. If both are present and no red flags exist, the clinical diagnosis of tendinopathy is established. Score severity with VISA-A, VISA-P, or PRTEE as appropriate, and begin a structured loading program (eccentric or heavy slow resistance exercise is first-line, supported by a Cochrane review of 23 RCTs) [17].

If the exam is equivocal, order musculoskeletal ultrasound. If ultrasound is normal or equivocal and symptoms persist beyond 12 weeks, proceed to MRI. If imaging reveals a partial tear, intra-articular pathology, or an unexpected finding, adjust the diagnosis and management accordingly.

For refractory cases (failure to improve after 12 weeks of supervised loading), consider adjunctive therapies. Extracorporeal shockwave therapy (ESWT) has moderate evidence for calcific rotator cuff tendinopathy, with a 2020 Cochrane review reporting a number needed to treat of 3 for complete calcium resorption [18]. Platelet-rich plasma (PRP) injections show mixed results: a 2021 JAMA Network Open meta-analysis of 18 RCTs found PRP superior to placebo for lateral elbow tendinopathy (mean difference of 12.1 points on a visual analogue scale at 6 months) but not for Achilles or patellar sites [19].

Special Populations and Considerations

Tendinopathy in patients over 60 requires additional caution. Age-related changes in tendon collagen cross-linking and vascularity mean that baseline ultrasound findings may include asymptomatic degeneration. Clinical correlation is mandatory, not optional.

In patients using testosterone replacement therapy (TRT) or anabolic agents, tendon stiffness may increase while collagen turnover decreases. A 2017 study in the Journal of Applied Physiology showed that supraphysiologic testosterone reduced tendon collagen synthesis by 18% compared with eugonadal controls [20]. Dose and duration should be documented when evaluating tendon complaints in this population.

Patients on GLP-1 receptor agonists undergoing rapid weight loss may experience altered lower-limb biomechanics as body mass changes. While no direct tendon toxicity has been reported with semaglutide or tirzepatide, clinicians should reassess footwear, orthotic needs, and training load as body composition shifts.

Fluoroquinolone-associated tendinopathy deserves emphasis. Risk peaks during the first month of use and persists up to 6 months after discontinuation. Patients over 60, those on concurrent corticosteroids, and organ transplant recipients carry the highest risk [4].